Opvee Opioid Rescue Spray Non-inferior to Intranasal Naloxone, Study Finds
A head-to-head pharmacodynamic study examined the ability of both intranasal nalmefene (Opvee) and intranasal naloxone to reverse opioid-induced respiratory depression.
Tag: opioid induced respiratory depression
All
Latest
All
Latest
Care Approach Reduces Hospital Stay of Opioid-exposed Newborns
The “Eat, Sleep, Console” (ESC) care approach to be more effective than using the Finnegan Neonatal Abstinence Scoring Tool to assess and manage opioid-exposed newborns.
All
Latest
Post-surgical Pediatric Opioid Prescriptions Plummet
Opioid prescriptions for children who underwent one of eight common outpatient surgeries declined over a period of five years, according to research published in Pediatrics.
Precise Pain Treatment for Sickle Cell Disease
Machine-learning strategies can be applied to routinely collected physiological data, such as heart rate and blood pressure, to provide clues about pain levels in people with sickle cell disease, according to new research.
Read More
Alternatives to Opioids for Sickle Cell Disease Patients
An enriched diet and companionship can reduce pain in mice with sickle cell disease by increasing serotonin, researchers say.
Read More
Evzio Naloxone Auto-injector and Generic Discontinued
Kaleo Inc has discontinued its naloxone hydrochloride injection product Evzio and its authorized generic, according to industry reports.
Read More
SARS-CoV-2 Infection Can Block Pain, Opening Up New Possibilities for Research Into Pain Relief Medication
People infected with SARS-CoV-2, the virus causing COVID-19, may be experiencing a dulled sense of pain.
Read More
Prenatal Opioid Exposure Linked to Pediatric Asthma
Children exposed to opioids in the womb had a two times higher rate of developing asthma, according to new research.
Read More
FDA Cracking Down on Illegal, Unapproved Opioids Sold Online
The FDA and National Telecommunications and Information Administration (NTIA) have launched a 120-day pilot program to reduce availability of unapproved opioids illegally offered for sale online.
Read More
10-year Study Found No OIRD Deaths with Continuous Monitoring
A 10-yr study of opioid-induced respiratory depression revealed zero deaths in patients continuously monitored with Masimo’s SafetyNet/SET technologies.
Read More
How Cannabinoids Can be Used to Treat Acute Pain
Cannabinoid treatment can lead to a reduction in subjective pain with no increase in serious adverse events, according to a study published in Cannabis and Cannabinoid Research.
Read More
States Reject Opioid Co’s $18B Offer to Settle Lawsuits
Three opioid manufacturers have made an $18 billion offer to settle lawsuits over their roles in the opioid epidemic. A group of 21 US states has rejected the offer.
Read More
A Breath Test for Opioids
A test to detect opioid drugs in exhaled breath has been developed by engineers and physicians. A...
Read More
FDA Continues to Support Increased Access to Naloxone
Access to naloxone remains limited but the FDA continues to support efforts to expand access in order to get the drug to those at risk of opioid overdose.
Read More
Naloxone Access Law in Pennsylvania Falls Short
A new study from researchers at the University of Illinois at Chicago finds that only one-third of pharmacies in Philadelphia carry naloxone nasal spray, a medication used to rapidly counter the effects of opioid overdose.
Read More